Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides

Arthritis and Rheumatism

Volumn 40, Issue 1, 1997, Pages 124-134

  Yellin, Michael J ^a   D'Agati, Vivette ^a   Parkinson, Glenn ^a   Han, Angelina Soh Yung ^a   Szema, Anthony ^a   Baum, David ^a   Estes, Dorothy ^a   Szabolcs, Matthias ^a   Chess, Leonard ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; GLOMERULONEPHRITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD40; BIOPSY; CD40 LIGAND; CHILD; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY DISEASES; LUPUS NEPHRITIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; UP-REGULATION;

EID: 0031027019     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400117     Document Type: Article

References (61)

1. Mohan C, Datta S: Lupus: key pathogenic mechanism and contributing factors. Clin Immunol Immunopathol 77:209-220, 1995
2. Hill G: Systemic lupus erythematosus and mixed connective tissue disease. In, Pathology of the Kidney. Fourth Edition. Edited by RH Heptinstall. Boston, Little Brown, 1992
3. D'Agati V, Appel G, Estes D, Knowles D II, Pirani C: Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 30:573-581, 1986
4. Cialigaris-Cappio F, Bergui L, Tesio L, Ziano R, Camussi G: HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clin Exp Immunol 59:185-189, 1985
5. Alexopoulos E, Seron D, Hartley R, Cameron J: Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37:100-109, 1990
6. Lederman S, Yellin MJ, Krichevsky A, Belko J, Lee JJ, Chess L: Identification of a novel surface protein on activated CD4 + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175:1091-1101, 1992
7. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis ST, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK: Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82, 1992
8. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: experssion of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313-4321, 1992
9. Noelle RJ, Roy M, Shepherd DM, Stamenkovic I, Ledbetter JA, Aruffo A: A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 89:6550-6554, 1992
10. Lederman S, Yellin MJ, Cleary AM, Fortune SM, Chess L: The understanding of contact-dependent T-cell helper function in molecular, cellular and physiological detail. Res Immunol 145:215-221, 1994
11. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922, 1994
12. Noelle RJ, Ledbetter JA, Aruffo A: CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 13:431-433, 1992
13. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM, Chess L: Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149:3817-3826, 1992
14. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669-674, 1993
15. Caux C, Massacrier C, Banbervliet B, Dubois B, van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263-1272, 1994
16. Galy AH, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149:775-782, 1992
17. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L: Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) upregulation, IL-6 production and proliferation. J Leukoc Biol 58:209-216, 1995
18. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: the role of CD40L-CD40 mediated signals. J Exp Med 182:1857-1864, 1995
19. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simons JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33-40, 1995
20. Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci U S A 92:4342-4346, 1995
21. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925-935, 1993
22. Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480, 1995
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
24. Pirani C, Salinas-Madrigal L, Koss M: Evaluation of renal biopsy. In, Pathology Decennial (1965-1975). First Edition. Edited by C Sommers. New York, Appleton Century Crofts, 1975
25. Austin H, Muenz L, Joyce KM, Antonovych TT, Balow JE: Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 25:689-695, 1984
26. Park M, D'Agati V, Appel G, Pirani C: Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309-319, 1986
27. Stamenkovic I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403-1410, 1989
28. Potocnik AJ, Kinne R, Menninger H, Zacher J, Emmrich F, Kroczek RA: Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 31:213-224, 1990
29. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D: Renal involvement in systemic lupus erythematosus: a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) 57:371-410, 1978
30. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ: Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330, 1993
31. Gerritse K, Laman J, Noelle R, Aruffo A, Ledbetter J, Boersma W, Claassen E: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 93:2499-2504, 1996
32. Young LS, Dawson CW, Brown KW, Rickinson AB: Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor of B lymphocytes. Int J Cancer 43:786-794, 1989
33. Platt J, LeBien T, Michael A: Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphopoietic differentiation antigens. J Exp Med 157:155-172, 1983
34. Cleary AM, Fortune SM, Yellin MJ, Chess L, Lederman S: Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J Immunol 155:3329-3337, 1995
35. Notarangelo L, Duse M, Ugazio A: Immunodeficency with hyperIgM (HIM). Immunodeficiency 3:101-122, 1992
36. Xu J. Foy TM, Laman JD, Elliot EA, Dunn JJ, Waldschmidt TJ, Elsemore J, Noelle RJ, Flavell RA: Mice deficient for the CD40 ligand. Immunity 1:423-431, 1994
37. Kawabe T, Naka T, Yoshida K, Tanaka T, Fujiwara H, Suematsu S, Yoshida N, Kishimoto T, Kikutani H: The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178, 1994
38. Biancone L, Andres G, Ahn H, DeMartino C, Stamenkovic I: Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis. Kidney Int 48:458-468, 1995
39. Schwartz M: Membranous glomerulopathy. In, Pathology of the Kidney. Fourth Edition. Edited by RH Heptinstall. Boston, Little Brown, 1992
40. Olson J: The nephrotic syndrome. In, Pathology of the Kidney. Fourth Edition. Edited by RH Heptinstall. Boston, Little Brown, 1992
41. 4L Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D: Activated human T cells express a ligand for the B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22:2573-2578, 1992
42. Yellin MJ, Sippel K, Inghirami G, Covey LR, Lee JJ, Sinning J, Clark EA, Chess L, Lederman S: CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L: potential role in regulating helper effector function. J Immunol 152:598-608, 1994
43. Van Kooten C, Gaillard C. Galizzi JP, Hermann P, Fossiez F, Banchereau J, Blanchard D: B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur J Immunol 24:787-792, 1994
44. Covey LR, Cleary AM, Yellin MJ, Ware R, Sullivan G, Belko J, Parker M, Rothman P, Chess L, Lederman S: Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand. Mol Immunol 31:471-484, 1994
45. Gauchat J, Henchoz S, Mazzei G, Aubry J, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy J: Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340-343, 1993
46. Gauchat J, Henchoz S, Fattah D, Mazzei G, Aubry J, Jomotte T, Dash L, Page K, Solari R, Aldebert D, Capron M, Dahinden C, Bonnefoy JY: CD40 ligand is functionally expressed on human eosinophils. Eur J Immunol 25:863-865, 1995
47. Grammer A, Bergman M, Miura Y, Fujita K, Davis L, Lipsky P: The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol 154:4996-5010, 1995
48. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta S: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97:2063-2073, 1996
49. Nath K: Tubulo-interstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17, 1992
50. Pichler R, Giachelli C, Lombardi D, Pippin J, Gordon K, Alpers C, Schwartz S, Johnson R: Tubulo-interstitial disease in glomerulonephritis. Am J Pathol 144:915-926, 1994
51. Wuthrich R: Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney. J Am Soc Nephrol 3:1201-1211, 1992
52. Brady H: Leukocyte adhesion molecules and kidney diseases. Kidney Int 45:1285-1300, 1994
53. Schmouder R, Strieter R, Wiggins R, Chensue S, Kunkel S: In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int 41:191-198, 1992
54. Von Asmuth E, Dentener M, Ceska M, Buurman W: IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro. Eur Cytokine Netw 5:301-310, 1994
55. Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, Maki S: Cellular localiztion of inflammatory cytokines in human glomerulonephritis. Virchows Arch 424:459-464, 1994
56. Malide D, Russo P, Bendayan M: Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 26:558-564, 1995
57. Yellin MJ, Sinning J, Covey LR, Sherman W, Lee JJ, Glickman NE, Sippel KC, Rogers J, Cleary AM, Parker M, Chess L, Lederman S: T lymphocyte T cell-B cell-activating molecule/ CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. J Immunol 153:666-674, 1994
58. Kennedy MK, Mohler KM, Shanebeck KD, Baum PR, Picha KS, Otten-Evans CA, Janeway CA, Grabstein KH: Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur J Immunol 24:116-123, 1994
59. Maliszewski CR, Grabstein K, Fanslow WC, Armitage R, Spriggs MK, Sato TA: Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines. Eur J Immunol 23:1044-1049, 1993
60. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 2:13-26, 1991
61. Hagerty D: Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells: discovery of a novel costimulator on kidney tubule cells. J Immunol 156:3652-3659, 1996